1. Home
  2. NEO vs BCX Comparison

NEO vs BCX Comparison

Compare NEO & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.18

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Resources of Beneficial Interest

BCX

BlackRock Resources of Beneficial Interest

HOLD

Current Price

$12.00

Market Cap

949.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
BCX
Founded
2001
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
949.9M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
BCX
Price
$9.18
$12.00
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.38
N/A
AVG Volume (30 Days)
2.0M
179.8K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
6.99%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$9.23
52 Week High
$13.74
$13.86

Technical Indicators

Market Signals
Indicator
NEO
BCX
Relative Strength Index (RSI) 59.70 43.06
Support Level $7.42 $11.91
Resistance Level $10.82 $12.58
Average True Range (ATR) 0.40 0.19
MACD 0.03 -0.04
Stochastic Oscillator 84.81 16.44

Price Performance

Historical Comparison
NEO
BCX

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BCX BlackRock Resources of Beneficial Interest

BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies, or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.

Share on Social Networks: